Anthem Blue Cross Blue Shield of Colorado prior authorization, page 39

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
77770Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 1 channelColorado Prior Authorization List, Pg 93 Original policy
77771Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 2-12 channelsColorado Prior Authorization List, Pg 93 Original policy
77772Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; over 12 channelsColorado Prior Authorization List, Pg 93 Original policy
77778Interstitial Radioelement Application; ComplexColorado Prior Authorization List, Pg 93 Original policy
77790Supervision, Handling, Loading, Radiation SourceColorado Prior Authorization List, Pg 93 Original policy
78429Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single sColorado Prior Authorization List, Pg 93 Original policy
78430Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at reColorado Prior Authorization List, Pg 93 Original policy
78431Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies atColorado Prior Authorization List, Pg 93 Original policy
78432Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], wColorado Prior Authorization List, Pg 93 Original policy
78433Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], wColorado Prior Authorization List, Pg 93 Original policy
78451Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall moColorado Prior Authorization List, Pg 93 Original policy
78452Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall moColorado Prior Authorization List, Pg 93 Original policy
78453Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall moColorado Prior Authorization List, Pg 93 Original policy
78454Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall moColorado Prior Authorization List, Pg 93 Original policy
78459Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single sColorado Prior Authorization List, Pg 94 Original policy
78466Myocardial Imaging, Infarct Avid, Planar; Qualitative/QuantitativeColorado Prior Authorization List, Pg 94 Original policy
78468Myocardial Imaging, Infarct Avid, Planar; W/Ejection Fraction, 1st Pass TechniqueColorado Prior Authorization List, Pg 94 Original policy
78469Myocardial Imaging, Infarct Avid, Planar; Tomographic Spect W/Wo QuantificationColorado Prior Authorization List, Pg 94 Original policy
78472Cardiac Blood Pool Imaging, Gated Equilibrium; Planar, Single Study, Rest/StressColorado Prior Authorization List, Pg 94 Original policy
78473Cardiac Blood Pool Imaging, Gated Equilibrium; Planar, Multiple Studies, Rest/StressColorado Prior Authorization List, Pg 94 Original policy
78481Cardiac Blood Pool Imaging, Planar, 1st Pass; Single Study & Ejection Fraction W/Wo QuantificationColorado Prior Authorization List, Pg 94 Original policy
78483Cardiac Blood Pool Imaging, Planar, 1st Pass; Mult Studies, Rest & Stress & Eject Fractn W/Wo QuantColorado Prior Authorization List, Pg 94 Original policy
78491Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at reColorado Prior Authorization List, Pg 94 Original policy
78492Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies atColorado Prior Authorization List, Pg 94 Original policy
78494Cardiac Blood Pool Imaging, Gated Equilibrium, Rest, Spect, & Ejection Fraction W/Wo QuantificationColorado Prior Authorization List, Pg 94 Original policy
78608Brain Imaging, Positron Emission Tomography (Pet); Metabolic EvaluationColorado Prior Authorization List, Pg 94 Original policy
78609Brain Imaging, Positron Emission Tomography (Pet); Perfusion EvaluationColorado Prior Authorization List, Pg 94 Original policy
78811Positron emission tomography (PET) imaging; limited area (eg, chest, head/neck)Colorado Prior Authorization List, Pg 94 Original policy
78812Positron emission tomography (PET) imaging; skull base to mid-thighColorado Prior Authorization List, Pg 94 Original policy
78813Positron emission tomography (PET) imaging; whole bodyColorado Prior Authorization List, Pg 94 Original policy
78814Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anColorado Prior Authorization List, Pg 94 Original policy
78815Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anColorado Prior Authorization List, Pg 94 Original policy
78816Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anColorado Prior Authorization List, Pg 94 Original policy
79101Radiopharmaceutical Therapy, By Intravenous AdministrationColorado Prior Authorization List, Pg 94 Original policy
79403Radiopharmaceutical Therapy, Radiolabeled Monoclonal Antibody By Intravenous InfusionColorado Prior Authorization List, Pg 94 Original policy
81120IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common variants (eg, R132H, R132C)Colorado Prior Authorization List, Pg 94 Original policy
81121IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common variants (eg, R140W, R172M)Colorado Prior Authorization List, Pg 94 Original policy
81161DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performedColorado Prior Authorization List, Pg 94 Original policy
81162BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplicatioColorado Prior Authorization List, Pg 95 Original policy
81163BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysisColorado Prior Authorization List, Pg 95 Original policy
81164BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, deColorado Prior Authorization List, Pg 95 Original policy
81165BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysisColorado Prior Authorization List, Pg 95 Original policy
81166BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)Colorado Prior Authorization List, Pg 95 Original policy
81167BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)Colorado Prior Authorization List, Pg 95 Original policy
81170ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domainColorado Prior Authorization List, Pg 95 Original policy
81171AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual disability 2 [FRAXE]) gene analysis; evaluation to detect abnormal (eg, expanded) allelesColorado Prior Authorization List, Pg 95 Original policy
81172AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual disability 2 [FRAXE]) gene analysis; characterization of alleles (eg, expanded size and methylaColorado Prior Authorization List, Pg 95 Original policy
81173AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; full gene sequenceColorado Prior Authorization List, Pg 95 Original policy
81174AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; known familial variantColorado Prior Authorization List, Pg 95 Original policy
81175ASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; fuColorado Prior Authorization List, Pg 95 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.